Authorized purpose: The Samsung V8, cV8, V7, cV7, V6, and cV6 systems provide general diagnostic ultrasound across broad applications. K243702 adds nerve, radiofrequency-ablation, strain, ejection-fraction/GLS, and transducer functions.
Clinical role
General diagnostic ultrasound acquisition, visualization, measurement, interventional support, and release-specific assisted analysis.
Images and patients
Ultrasound · Multi-region
Key limitation
Keep in mind: EzNerveMeasure, NerveTrack, RFA Viewer, Strain+ LA/RV, AutoEF GLS, and BCL2-14 support are application and model dependent. Verify each feature’s labeled population and compatible probe.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: The Samsung V8, cV8, V7, cV7, V6, and cV6 systems provide general diagnostic ultrasound across broad applications. K243702 adds nerve, radiofrequency-ablation, strain, ejection-fraction/GLS, and transducer functions.
Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Multi-region Input: Real-time ultrasound data from compatible probes, with application-specific ECG or tracking inputs where supported.
Who uses it?Intended users: Physicians and other qualified healthcare professionals trained in diagnostic ultrasound.
What does the software produce?Output: Ultrasound images, Doppler information, measurements, strain or cardiac analysis, and procedure-support displays.
What is its most important limitation?Key limitation: EzNerveMeasure, NerveTrack, RFA Viewer, Strain+ LA/RV, AutoEF GLS, and BCL2-14 support are application and model dependent. Verify each feature’s labeled population and compatible probe.
Clinical takeaway. Clinical role: The Samsung V8, cV8, V7, cV7, V6, and cV6 systems provide general diagnostic ultrasound across broad applications. K243702 adds nerve, radiofrequency-ablation, strain, ejection-fraction/GLS, and transducer functions.
Evidence takeaway. Evidence from the reviewed source record: K243702 describes manufacturer verification of the added nerve, cardiac, ablation-viewing, probe, image-quality, safety, and software functions. Public V8 material is product-family context rather than exact-version comparative evidence.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
The Samsung V8, cV8, V7, cV7, V6, and cV6 systems provide general diagnostic ultrasound across broad applications. K243702 adds nerve, radiofrequency-ablation, strain, ejection-fraction/GLS, and transducer functions.
EzNerveMeasure, NerveTrack, RFA Viewer, Strain+ LA/RV, AutoEF GLS, and BCL2-14 support are application and model dependent. Verify each feature’s labeled population and compatible probe.
K243702 describes manufacturer verification of the added nerve, cardiac, ablation-viewing, probe, image-quality, safety, and software functions. Public V8 material is product-family context rather than exact-version comparative evidence.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
K243702 describes manufacturer verification of the added nerve, cardiac, ablation-viewing, probe, image-quality, safety, and software functions. Public V8 material is product-family context rather than exact-version comparative evidence.
Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or dose-delivery function. Use the task-specific endpoints and tested population reported below.
Reported specificity
Not applicable
Not applicable
Exact FDA submission
Checked 2026-09-04
Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or dose-delivery function. Use the task-specific endpoints and tested population reported below.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K243702 FDA performance package for V8 Diagnostic Ultrasound System; cV8 Diagnostic Ultrasound System; V7 Diagnostic Ultrasound System; cV7 Diagnostic Ultrasound System; V6 Diagnostic Ultrasound System; cV6 Diagnostic Ultrasound System
K243702 FDA evidence package for V8 Diagnostic Ultrasound System; cV8 Diagnostic Ultrasound System; V7 Diagnostic Ultrasound System; cV7 Diagnostic Ultrasound System; V6 Diagnostic Ultrasound System; cV6 Diagnostic Ultrasound System
DesignFDA 510(k) verification and validation evidence described in the exact submission
PopulationMulti-region
Scopeexact submission
Tested versionSamsung V8/cV8/V7/cV7/V6/cV6 diagnostic ultrasound systems and probes
IndependenceSponsor or vendor study
K243702
Manufacturer evidence submitted for the exact FDA decision. It is not independent clinical validation, and local technical, clinical, privacy, security, and workflow acceptance remains necessary.
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the device within the applicable imaging or surgical service line and verify payer, site-of-service, and coding assumptions independently.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: Real-time ultrasound data from compatible probes, with application-specific ECG or tracking inputs where supported.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: DICOM and network workflow depend on exact system configuration; test worklist, archive, measurement, clip, and report exchange.
Scope: Exact FDA submission.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Unresolved route: Ultrasound images, Doppler information, measurements, strain or cardiac analysis, and procedure-support displays.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
Samsung Healthcare USA's security advisories page, published under Boston Imaging (a Samsung company), posts vulnerability impact analyses and patch process statements for Samsung computed tomography, ultrasound and digital radiography modalities (including Log4j, Urgent11, BlueKeep and WannaCry analyses).
Vendor-wide
Checked 2026-10-26
Vendor statement, not an attestation. Identity bridge: owning-domain press releases on usa.samsunghealthcare.com state that Boston Imaging is Samsung Medison's U.S. medical imaging business (unified as Samsung HME America, March 2026) and that Samsung Medison is an affiliate of Samsung Electronics. Corporate program statement; exact-release scope is not established.
Only physicians and other qualified healthcare professionals trained in diagnostic ultrasound. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: EzNerveMeasure, NerveTrack, RFA Viewer, Strain+ LA/RV, AutoEF GLS, and BCL2-14 support are application and model dependent. Verify each feature’s labeled population and compatible probe.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. EzNerveMeasure, NerveTrack, RFA Viewer, Strain+ LA/RV, AutoEF GLS, and BCL2-14 support are application and model dependent. Verify each feature’s labeled population and compatible probe.
exact submission · checked 2026-09-04
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
product family · checked 2026-09-04
Vendor productivity claims are scenario inputs, not guaranteed local savings.
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: EzNerveMeasure, NerveTrack, RFA Viewer, Strain+ LA/RV, AutoEF GLS, and BCL2-14 support are application and model dependent. Verify each feature’s labeled population and compatible probe.
exact submission · checked 2026-09-04
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-04Last searched
25Fields reviewed
11Source classes checked
20Screened PubMed leads
10Screened trial leads
0Unreviewed FDA recall leads
Screened 20 PubMed titles and 10 trial records. They are generic diagnostic-ultrasound or unrelated clinical records and do not identify the Samsung V8/cV8/V7/cV7/V6/cV6 K243702 release; all 30 are quarantined. The current discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, vendor product page, reimbursement policy, fda device recall, fda decision material, peer reviewed literature, clinical trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission
No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
Ge Medical Systems Ultrasound and Primary Care Diagnostics
Authorized purpose: LOGIQ E10s is a general-purpose diagnostic ultrasound system supporting the labeled adult, pediatric, cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, and procedural applications.
Ge Medical Systems Ultrasound and Primary Care Diagnostics
Authorized purpose: LOGIQ E10 is a general diagnostic ultrasound system for qualified users across fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, breast, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative applications.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.